Different immune cell populations influence the severity of cardiac inflammation after myocardial infarction (MI), which ...

A Myocardial Infarction, commonly known as a heart attack, is a life-threatening event that occurs when the heart does not ...

A heart attack is far from an isolated, acute event. The consequences of an attack can cause serious and lasting damage, ...

Despite the high rate of sudden death after myocardial infarction among patients with a low ejection fraction, implantable cardioverter–defibrillators are contraindicated until 40 to 90 days after ...

A bivalent messenger RNA vaccine targeting both the ancestral and omicron BA.4–BA.5 sublineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Pfizer–BioNTech) was introduced in ...

Myocardial infarction (MI) – more regularly known as a heart attack – is an acute phenomenon initiated by the interruption of blood supply to regions of the heart, causing myocardial necrosis.

The acute myocardial infarction market is experiencing steady growth driven by rising global cardiovascular disease prevalence and expanding geriatric populations. Advances in diagnostic technologies ...

Researchers from The University of Osaka found that nanomicelle-mediated delivery of five mRNAs involved in angiogenesis, ...

Recently published Acute Myocardial Infarction Market Insights report includes a comprehensive understanding of current treatment practices, acute myocardial infarction emerging drugs, market share of ...